University of Texas Medical Branch
Dermatology residency · Galveston, TX · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is The University of Texas Medical Branch at Galveston's research in dermatology, which the program shares with other departments and affiliated hospitals.
About The University of Texas Medical Branch at Galvestoninstitution-wide dermatology research
Dermatology publications from The University of Texas Medical Branch at Galveston and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
22
works per year
33rd of 58 dermatology residency programs
+35.1%
2-year growth
17th of 58 dermatology residency programs
14.3%
in top 10% of field (works before 2025)
29th of 50 dermatology residency programs
30.4%
cited above world average
38th of 50 dermatology residency programs
Works per year · * 2026 so far
Dermatology · 120
Dermatology research topics at The University of Texas Medical Branch at Galveston
Papers in the window; each links to the list on OpenAlex.
Most cited at The University of Texas Medical Branch at Galveston since 2024
All dermatology papers there on OpenAlex
- Benzoyl peroxide for acne treatment is not associated with an increased risk of malignancy: A retrospective cohort studyDavid Gárate et al. · Journal of the American Academy of Dermatology · 2024 · PubMed · cited 18
- A case of a rash after tetanus-diphtheria-pertussis and meningococcal vaccinationLeonardo Salazar et al. · Allergy and Asthma Proceedings · 2024 · PubMed · cited 9
- Response-Adapted Oncologic Surgery in Cutaneous Squamous Cell Carcinoma: A Paradigm Shift Following Neoadjuvant ImmunotherapyDan Yaniv et al. · Annals of Surgical Oncology · 2025 · PubMed · cited 8
- Association between hidradenitis suppurativa and increased risk of venous thromboembolism: A multicenter retrospective cohort studyDavid Gárate et al. · Journal of the American Academy of Dermatology · 2024 · PubMed · cited 8
- Systemic risk profiles of topical ruxolitinib and oral Janus kinase inhibitors in patients with atopic dermatitis: A retrospective cohort study from the TriNetX networkKatherine Benandi et al. · Journal of the American Academy of Dermatology · 2025 · PubMed · cited 7
- Risk of malignancy associated with use of dupilumab versus other treatments in atopic dermatitis patients: A national database analysisDavid Gárate et al. · The Journal of Allergy and Clinical Immunology In Practice · 2024 · PubMed · cited 7
- Calcitonin Gene-Related Peptide Inhibition and Development of Acne and RosaceaChristopher J Thang et al. · JAMA Dermatology · 2024 · PubMed · cited 6
- A matched cohort study evaluating whether spironolactone or tetracycline-class antibiotic use among female acne patients is associated with breast cancer development riskDavid Gárate et al. · Archives of Dermatological Research · 2024 · PubMed · cited 6
- Dupilumab treatment for atopic dermatitis associated with reduced risk of alopecia areata: A multicenter cohort studyJasmine P. Levine et al. · The Journal of Allergy and Clinical Immunology In Practice · 2026 · PubMed · cited 4
- Decreased risk of cardiovascular disease in dermatology patients taking niacinamide: A TriNetX cohort studyYousef Salem et al. · Journal of the American Academy of Dermatology · 2025 · PubMed · cited 4